4D Molecular Therapeutics to Participate in the SVB Securities Global Biopharma Conference

Wednesday, February 8, 2023 1 min read

Key Takeaway: 4D Molecular Therapeutics to Participate in the SVB Securities Global Biopharma Conference

Full Press Release Details

4D Molecular Therapeutics to Participate in the SVB Securities Global Biopharma Conference.